GlaxoSmithKline
GSK
#208
Rank
S$127.03 B
Marketcap
S$62.93
Share price
-0.82%
Change (1 day)
40.78%
Change (1 year)

GlaxoSmithKline (GSK) - Total debt

Total debt on the balance sheet as of September 2025 : S$30.91 Billion

According to GlaxoSmithKline's latest financial reports the company's total debt is S$30.91 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

GlaxoSmithKline - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$28.97 B-4.43%
2023-12-31S$30.31 B-10.93%
2022-12-31S$34.03 B-22.84%
2021-12-31S$44.11 B-9.9%
2020-12-31S$48.95 B-9.23%
2019-12-31S$53.93 B19.33%
2018-12-31S$45.19 B46.32%
2017-12-31S$30.89 B-7.94%
2016-12-31S$33.55 B-3.75%
2015-12-31S$34.86 B-9.78%
2014-12-31S$38.64 B1.34%
2013-12-31S$38.13 B5.4%
2012-12-31S$36.17 B20.61%
2011-12-31S$29.99 B-0.11%
2010-12-31S$30.02 B-18.7%
2009-12-31S$36.93 B8.86%
2008-12-31S$33.92 B12.16%
2007-12-31S$30.25 B83.52%
2006-12-31S$16.48 B-22.05%
2005-12-31S$21.14 B13.27%
2004-12-31S$18.66 B20.53%
2003-12-31S$15.48 B19.9%
2002-12-31S$12.91 B13.46%
2001-12-31S$11.38 B9.16%
2000-12-31S$10.42 B10.45%
1999-12-31S$9.44 B10.21%
1998-12-31S$8.56 B2.37%
1997-12-31S$8.36 B7.63%
1996-12-31S$7.77 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
S$42.28 B 36.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$78.84 B 155.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$53.60 B 73.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$41.49 B 34.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
S$33.08 B 7.00%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
S$22.12 B-28.45%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
S$0.36 B-98.81%๐Ÿ‡บ๐Ÿ‡ธ USA